Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-08

Clinical Trial Update: Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe Preeclampsia [NA]

View source ↗

Summary

A clinical trial evaluating abbreviated postpartum magnesium sulfate for severe preeclampsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University of Chicago | Conditions: Patient Satisfaction | NA | Status: WITHDRAWN